Cafepharma | Pharmaceutical Sales, Medical Sales, Lab Sales

Cafepharma Today

April 16 2024 - J&J narrowly misses Q1 revenue on lower-than-expected Stelara sales

J&J narrowly misses Q1 revenue on lower-than-expected Stelara sales
Ukraine was pharma’s ‘darling’ of clinical trials. As war drags on, will the industry come back?
Humira biosimilar scripts take off
Intra-Cellular launches 26% to record high, breaking out after depression drug scores big
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Could Amarin Be an Acquisition Target?

Motley Fool

Friday, September 21, 2012 - 11:29am

tags:

Amarin, M&A, GSK

FDA: Boehringer Parkinson's med may boost heart failure risk

Fierce Pharma

Thursday, September 20, 2012 - 12:05pm

tags:

FDA, Boehringer Ingelheim, Parkinson's Disease, Mirapex

Is Big Pharma getting too much flak from doctors?

Reuters

Thursday, September 20, 2012 - 12:02pm

tags:

physicians, Big Pharma

Bayer CEO decries pressure to lower drug prices

Reuters

Thursday, September 20, 2012 - 11:55am

tags:

Bayer, Pharma CEOs, drug pricing, Marijn Dekkers

Neuralstem Reminds Investors Of Stem Cell Rewards And Risk

Seeking Alpha

Thursday, September 20, 2012 - 11:45am

tags:

stem cells, Neuralstem

Bayer seeks EU approval for birth control patch

Reuters

Thursday, September 20, 2012 - 11:19am

tags:

Bayer, Europe, contraceptive patch, JNJ, Ortho Evra

Sunshine on the FDA

Motley Fool

Thursday, September 20, 2012 - 11:18am

tags:

FDA, drug approvals, advisory panels

2 Big Events For Obesity Drugmakers

Motley Fool

Thursday, September 20, 2012 - 11:10am

tags:

obesity, Arena Pharmaceuticals, Vivus, Qsymia, Belviq

Celgene's Drug Pipeline News Soothes Investor Worries

Investors.com

Thursday, September 20, 2012 - 11:01am

tags:

Celgene, psoriatic arthritis, Revlimid, apremilast

FDA Makes This Biotech Less Risky

Motley Fool

Thursday, September 20, 2012 - 10:59am

tags:

FDA, Ariad Pharmaceuticals

Sanofi: A Long-Term Winner On These FDA Approvals

Seeking Alpha

Thursday, September 20, 2012 - 10:58am

tags:

Sanofi, FDA, Aubagio, Zaltrap

10 drugmakers team up to improve testing process

Yahoo/AP

Thursday, September 20, 2012 - 10:38am

tags:

TransCelerate BioPharma, Pfizer, JNJ, Bristol-Myers Squibb, Eli Lilly, Abbott Laboratories, GSK, AstraZeneca, Sanofi, Boehringer Ingelheim, Genentech

Horizon Pharma plans offering of stock, warrants

Yahoo/AP

Thursday, September 20, 2012 - 10:30am

tags:

Horizon Pharma, stock offering

Glaxo Aims to Expand Synflorix Label

Yahoo/Zacks

Wednesday, September 19, 2012 - 11:51am

tags:

GSK, Synflorix, Theravance, streptococcus pneumoniae, vaccines

Valeant announces $1.75 bln debt offering to fund Medicis deal

Reuters

Wednesday, September 19, 2012 - 11:45am

tags:

Medicis, Valeant Pharmaceuticals, M&A

Lundbeck to stop making cancer drug Elspar

Fierce Pharma

Wednesday, September 19, 2012 - 11:43am

tags:

Lundbeck, Elspar, leukemia

NPSP Begins Run-Up into FDA Advisory Panel, Approval

Yahoo/Reuters

Wednesday, September 19, 2012 - 11:41am

tags:

FDA, advisory panels, NPS Pharmaceuticals, short bowel syndrome, Gattex

Questcor plunges 42% on drug reimbursement worries

Marketwatch

Wednesday, September 19, 2012 - 11:31am

tags:

Questcor, Aetna, Acthar

Achillion Back On The Hep C Roller Coaster Of Love

Seeking Alpha

Wednesday, September 19, 2012 - 11:30am

tags:

Achillion, hepatitis C, Abbott Labs, Gilead, JNJ, Merck, Pfizer, ACH-1625

Synergy Pharmaceuticals: Positioning For Pipeline Payoff

Seeking Alpha

Wednesday, September 19, 2012 - 11:14am

tags:

Synergy Pharmaceuticals, plecanatide, chronic idiopathic constipation, Ironwood

Pages

Latest CP Wire Articles

PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition

Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research

First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study

Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth

Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Sapio Sciences launches new drug discovery platform

Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics

Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business

Bend Bioscience Adds Capacity and Technology Offerings with the Addition of New Process and Manufacturing Science Facility

Eastman introduces new excipient to formulate poorly soluble API

Latest Pharmagather Articles

How Patient Engagement Can Reduce Brand Launch Risks

Drug Channels

The Top Pharmacy Benefit Managers of 2023: Market Share and Trends for the Biggest Companies—And What’s Ahead

Drug Channels

SAVE THE DATE: Drug Channels Leadership Forum, March 17-19, 2025

Drug Channels

Tales of the Unsurprised: U.S. Brand-Name Drug Prices Fell for an Unprecedented Sixth Consecutive Year—And Will Fall Further in 2024 (rerun)

Drug Channels

Vertical Integration Lessons: The Economics and Strategies of Hospital-Owned Specialty Pharmacies (rerun)

Drug Channels

The Big Three PBMs’ 2024 Formulary Exclusions: Biosimilar Humira Battles, CVS Health’s Weird Strategy, and the Insulin Shakeup (rerun)

Drug Channels

What CVS Pharmacy’s New Cost-Plus Reimbursement Approach Means for PBMs, Pharmacies, Plan Sponsors, and Prescription Prices (rerun)

Drug Channels

Understanding CVS Health/McKesson and Why Pharmacies Lose Money on GLP-1s (rerun)

Drug Channels

Navigating Market Access Challenges in Life Sciences Commercialization

Drug Channels